These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2848757)

  • 1. Molecular studies of haemophilia B in Sweden. Identification of patients with total deletion of the factor IX gene and without inhibitory antibodies.
    Wadelius C; Blombäck M; Pettersson U
    Hum Genet; 1988 Dec; 81(1):13-7. PubMed ID: 2848757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA analysis of seven patients with hemophilia B who have anti-factor IX antibodies: relationship to clinical manifestations and evidence that the abnormal gene was inherited.
    Tanimoto M; Kojima T; Kamiya T; Takamatsu J; Ogata K; Obata Y; Inagaki M; Iizuka A; Nagao T; Kurachi K
    J Lab Clin Med; 1988 Sep; 112(3):307-13. PubMed ID: 3411192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients.
    Anson DS; Blake DJ; Winship PR; Birnbaum D; Brownlee GG
    EMBO J; 1988 Sep; 7(9):2795-9. PubMed ID: 2846283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).
    Peake IR; Furlong BL; Bloom AL
    Lancet; 1984 Feb; 1(8371):242-3. PubMed ID: 6142993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene.
    Hassan HJ; Leonardi A; Guerriero R; Chelucci C; Cianetti L; Ciavarella N; Ranieri P; Pilolli D; Peschle C
    Blood; 1985 Sep; 66(3):728-30. PubMed ID: 2992643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene deletions in patients with haemophilia B and anti-factor IX antibodies.
    Giannelli F; Choo KH; Rees DJ; Boyd Y; Rizza CR; Brownlee GG
    Nature; 1983 May 12-18; 303(5913):181-2. PubMed ID: 6843667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intragenic deletion of the factor IX gene in a family with hemophilia B.
    Chen SH; Yoshitake S; Chance PF; Bray GL; Thompson AR; Scott CR; Kurachi K
    J Clin Invest; 1985 Dec; 76(6):2161-4. PubMed ID: 3001143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier detection through the use of abnormal deletion junction fragments in a case of haemophilia B involving complete deletion of the factor IX gene.
    Matthews RJ; Peake IR; Bloom AL; Anson DS
    J Med Genet; 1988 Nov; 25(11):779-80. PubMed ID: 2907054
    [No Abstract]   [Full Text] [Related]  

  • 10. Extragenic factor IX gene RFLP is useful for detecting carriers of Japanese hemophilia B.
    Tanimoto M; Kojima T; Ogata K; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):774-7. PubMed ID: 2575831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred.
    Taylor SA; Lillicrap DP; Blanchette V; Giles AR; Holden JJ; White BN
    Hum Genet; 1988 Jul; 79(3):273-6. PubMed ID: 2841226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
    Matthews RJ; Anson DS; Peake IR; Bloom AL
    J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial deletion by illegitimate recombination of the factor IX gene in a haemophilia B family with two inhibitor patients.
    Green PM; Bentley DR; Mibashan RS; Giannelli F
    Mol Biol Med; 1988 Apr; 5(2):95-106. PubMed ID: 3398774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
    Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
    Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with hemophilia B (Christmas disease) who have anti-factor IX: genetic heterogeneity.
    Poon MC
    J Lab Clin Med; 1988 Sep; 112(3):283-4. PubMed ID: 3411190
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.
    Bray GL; Thompson AR
    J Clin Invest; 1986 Apr; 77(4):1194-200. PubMed ID: 3514676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragenic Factor IX restriction site polymorphism in hemophilia B variants.
    Hassan HJ; Orlando M; Leonardi A; Chelucci C; Guerriero R; Mannucci PM; Mariani G; Peschle C
    Blood; 1985 Feb; 65(2):441-3. PubMed ID: 2981590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of human factor IX inhibitor antibodies.
    Takahashi I; Mizumo S; Kamiya T; Takamatsu J; Saito H
    Br J Haematol; 1994 Sep; 88(1):166-73. PubMed ID: 7528527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: non-homologous recombination associated with a shortened transcript from whole blood.
    Hsu TC; Nakaya SM; Thompson AR
    Thromb Haemost; 2007 Feb; 97(2):176-80. PubMed ID: 17264943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of factor IX allotypes for carrier identification in haemophilia B.
    Wallmark A; Ljung R; Nilsson IM
    Br J Haematol; 1987 Dec; 67(4):427-32. PubMed ID: 3426960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.